Accès libre

Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis

Miha Koren

Miha Koren

Institute of Pathology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Koren, Miha
, 
Margareta Zlajpah

Margareta Zlajpah

Institute of Pathology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Zlajpah, Margareta
, 
Mario Poljak

Mario Poljak

Institute of Microbiology and Immunology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Poljak, Mario
, 
Kristina Fujs Komlos

Kristina Fujs Komlos

Institute of Microbiology and Immunology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Komlos, Kristina Fujs
 et 
Margareta Strojan Flezar

Margareta Strojan Flezar

Institute of Pathology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Recherchez cet auteur sur
Sciendo|Google Scholar
Flezar, Margareta Strojan
  
24 avr. 2025
Expression of the stem cell markers NANOG and SOX2 in the cervical squamous carcinogenesis's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Télécharger la couverture
Catégorie d'article: research article
Publié en ligne: 24 avr. 2025
Pages: 213 - 224
Reçu: 05 mars 2025
Accepté: 26 mars 2025
DOI: https://doi.org/10.2478/raon-2025-0026
Mots clés
© 2025 Miha Koren et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.

Figure 1.

Representative images of p16 (b, g, l, q, v), Ki-67 (c, h, m r, w), NANOG (d, i, n, s, x) and SOX2 (e, j, o, t, y) immunohistochemical staining in a control (a-e), low-grade squamous intraepithelial lesion (LSIL) (f-j), high-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 2 (HSIL/CIN 2) (k-o), high-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 3 (HSIL/CIN 3) (p-t) and cervical squamous cell carcinoma (CSCC) (u-y). HE = haematoxylin and eosin stain
Representative images of p16 (b, g, l, q, v), Ki-67 (c, h, m r, w), NANOG (d, i, n, s, x) and SOX2 (e, j, o, t, y) immunohistochemical staining in a control (a-e), low-grade squamous intraepithelial lesion (LSIL) (f-j), high-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 2 (HSIL/CIN 2) (k-o), high-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 3 (HSIL/CIN 3) (p-t) and cervical squamous cell carcinoma (CSCC) (u-y). HE = haematoxylin and eosin stain

Comparison of NANOG and SOX2 staining between squamous lesions and their adjacent control non-dysplastic squamous epithelium

NANOG SIxP score, a ± SD p-value1 SOX2 SIxP score, a ± SD p-value1
C (LSIL) LSIL C (LSIL) LSIL
2.30 ± 0.95 7.50 ± 2.46 0.000 3.00 ± 1.41 5.40 ± 2.63 0.054
C (HSIL/CIN 2) HSIL/CIN 2 C (HSIL/CIN 2) HSIL/CIN 2
3.30 ± 2.06 9.20 ± 3.79 0.002 2.20 ± 1.48 7.70 ± 2.75 0.000
C (HSIL/CIN 3) HSIL/CIN 3 C (HSIL/CIN 3) HSIL/CIN 3
2.00 ± 0.94 10.40 ± 2.07 0.000 2.30 ± 1.16 10.10 ± 3.84 0.002
C (CSCC) CSCC C (CSCC) CSCC
1.44 ± 1,01 11.56 ± 1.33 0.000 2.44 ± 0,53 10.22 ± 2.73 0.000
C (HSIL) HSIL C (HSIL) HSIL
2.65 ± 1.65 9.80 ± 2.96 0.000 2.25 ± 1.26 8.90 ± 3.39 0.000

Comparison of NANOG and SOX2 staining between squamous lesions

NANOG SIxP score, a ± SD p-value1 SOX2 SIxP score, a ± SD p-value1
LSIL HSIL/CIN 2 LSIL HSIL/CIN 2
7.50 ± 2.46 9.20 ± 3.79 0.101 5.40 ± 2.63 7.70 ± 2.75 0.114
HSIL/CIN 2 HSIL/CIN 3 HSIL/CIN 2 HSIL/CIN 3
9.20 ± 3.79 10.40 ± 2.07 0.547 7.70 ± 2.75 10.10 ± 3.84 0.031
HSIL/CIN 3 CSCC HSIL/CIN 3 CSCC
10.40 ± 2.07 11.56 ± 1.33 0.165 10.10 ± 3.84 10.22 ± 2.73 0.805
LSIL HSIL LSIL HSIL
7.50 ± 2.46 9.80 ± 2.96 0.018 5.40 ± 2.63 8.90 ± 3.39 0.009
HSIL CSCC HSIL CSCC
9.80 ± 2.96 11.56 ± 1.33 0.078 8.90 ± 3.39 10.22 ± 2.73 0.370

Results of human papillomavirus (HPV) genotyping in squamous lesions

HPV type HPV 16 HPV 18 HPV 31 HPV 39 HPV 51 HPV 52 HPV 53 HPV 56 HPV 58 HPV 59 HPV 68 HPV 66 HPV 70 HPV 42
LSIL, n 4 0 0 3 2 0 3 1 0 1 2 5 2 2
HSIL/CIN 2, n 4 1 1 0 1 2 0 1 2 0 0 1 0 0
HSIL/CIN 3, n 8 0 3 0 0 0 1 0 0 1 0 0 0 0
CSCC, n 6 2 2 0 3 0 0 0 0 0 0 0 1 0

Evaluation of SOX2 staining in controls and squamous lesions

SOX2 SI, n (%) SOX2 P, n (%) SOX2 T, n (%)
Score 0 1 2 3 0 1 2 3 4 0 1 2 3
Controls (n = 40) 2 (5) 33 (82.5) 5 (12.5) 0 (0) 2 (5) 1 (2.5) 26 (65) 10 (25) 0 (0) 2 (5) 1 (2.5) 31 (77.5) 6 (15)
LSIL (n = 10) 0 (0) 4 (40) 6 (60) 0 (0) 0 (0) 0 (0) 2 (20) 4 (40) 4 (40) 0 (0) 0 (0) 4 (40) 6 (60)
HSIL/CIN 2 (n = 10) 0 (0) 1 (10) 7 (70) 2 (20) 0 (0) 0 (0) 0 (0) 4 (40) 6 (60) 0 (0) 0 (0) 1 (10) 9 (90)
HSIL/CIN 3 (n = 10) 0 (0) 1 (10) 1 (10) 8 (80) 1 (10) 0 (0) 0 (0) 1 (10) 8 (80) 0 (0) 0 (0) 0 (0) 10 (100)
CSCC (n = 10) 0 (0) 0 (0) 3 (30) 7 (70) 0 (0) 0 (0) 0 (0) 2 (20) 8 (80) Not applicable1

Evaluation of NANOG staining in controls and squamous lesions

NANOG SI, n (%) NANOG P, n (%) NANOG T, n (%)
Score 0 1 2 3 0 1 2 3 4 0 1 2 3
Controls (n = 40) 3 (7.5) 32 (80) 5 (12.5) 0 (0) 3 (7.5) 6 (15) 22 (55) 8 (20) 1 (2.5) 3 (7.5) 4 (10) 28 (70) 5 (12.5)
LSIL (n = 10) 0 (0) 2 (20) 7 (70) 1 (10) 0 (0) 0 (0) 0 (0) 1 (10) 9 (90) 0 (0) 0 (0) 0 (0) 10 (100)
HSIL/CIN 2 (n = 10) 1 (10) 0 (0) 4 (40) 5 (50) 1 (10) 0 (0) 0 (0) 0 (0) 9 (90) 1 (0) 0 (0) 0 (0) 9 (90)
HSIL/CIN 3 (n = 10) 0 (0) 0 (0) 1 (10) 9 (90) 0 (0) 0 (0) 0 (0) 0 (0) 10 (10) 0 (0) 0 (0) 0 (0) 10 (100)
CSCC (n = 10) 0 (0) 0 (0) 1 (10) 9 (90) 0 (0) 0 (0) 0 (0) 0 (0) 10 (100) Not applicable1
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Médecine, Médecine clinique, Médecine interne, Hématologie, oncologie, Radiologie
RSS Feed de la revue